Patents expiring in 2036

US 9528109

Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9527819

Pyridazine compounds, compositions and methods

Northwestern University · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9527807

Sulfonamide derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9527841

Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9526760

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9526769

Macrocylic oximyl hepatitis C protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9526882

Percutaneous administration device and method for producing the same

OPTNICS PRECISION CO., LTD. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9526803

Diagnostic chewing gum for pathogens

Julius-Maximilians-Universitat Wurzburg · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2016209959

COMBINAISONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX POLLEN DE CÈDRE

ALK-ABELLÓ AS [DK] · Granted Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2985531

COMPOSITION DEODORANTE COMPRENANT UN MELANGE D'ALPHA-, BETA- ET GAMMA- CYCLODEXTRINE

ACRAF [IT] · Granted Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

CH 711279

Verpacktes Arzneimittel, umfassend eine Retardformulierung von Naloxon oder einem pharmazeutisch verträglichen Salz davon, und eine Verpackung.

ACINO PHARMA AG [CH] · Granted Fri Dec 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533039

Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534044

Alpha-synuclein antibodies and uses thereof

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532555

Humanized dipeptidyl peptidase IV (DPP4) animals

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532994

Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532989

Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532998

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9532948

Nanostructure suitable for sequestering cholesterol and other molecules

Northwestern University · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533014

Synergistic bacterial compositions and methods of production and use thereof

Seres Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533962

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533966

Cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533947

Benzamide compounds and related methods of use

Northwestern University · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533045

Photothermal therapy using magnetic nanoparticles

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533981

Pyridine derivatives

Asana BioSciences, LLC · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533987

Heterocyclic derivates

KalVista Pharmaceuticals Limited · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534007

Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534008

Small molecule compounds that control plant- and insect-pathogenic nematodes

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534041

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534033

Targeted interferons demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9535076

Methods and compositions for eliciting an amyloid-selective immune response

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534277

Method for purification of 225AC from irradiated 226RA-targets

Actinium Phamaceuticals, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533031

Yeast-MUC1 immunotherapeutic compositions and uses thereof

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533990

Inhibitors of secretion of hepatitis B virus antigens

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533025

Method for treating chemotherapy-induced male infertility

The Board of Regents of the University of Texas System · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9534220

Antisense antibacterial method and compound

Sarepta Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017004561

ASSOCIATIONS DE PEPTIDES ET LEURS UTILISATIONS DANS LE TRAITEMENT DE L'ALLERGIE AUX GRAMINÉES

ALK-ABELLÓ AS [DK] · Granted Thu Jan 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)